Literature DB >> 2728038

Early collateral blood supply and late parenchymal brain damage in patients with middle cerebral artery occlusion.

L Bozzao1, L M Fantozzi, S Bastianello, A Bozzao, C Fieschi.   

Abstract

We angiographically studied 80 patients within 6 hours after the onset of ischemic supratentorial infarction. From this group we selected 36 patients with middle cerebral artery occlusion who survived. In these 36 patients, we compared the presence of a collateral blood supply during the early phase with the extent of final parenchymal brain damage obtained by computed tomography 3 months after the event. The presence of a collateral circulation during the first few hours after the stroke reduced the size of the final parenchymal brain damage in patients with middle cerebral artery stem-trunk occlusion. The collateral blood supply was more efficient in patients who had no significant stenosing lesions of the extracranial internal carotid artery. Our data confirm that the lenticulostriate arteries are end arteries not supplied by collateral blood vessels and suggest that lesions formerly thought to be caused by hemodynamic mechanisms (watershed infarcts) or arteriolar lesions (lacunar infarcts) may be due to middle cerebral artery occlusions.

Entities:  

Mesh:

Year:  1989        PMID: 2728038     DOI: 10.1161/01.str.20.6.735

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  30 in total

Review 1.  Systematic review of methods for assessing leptomeningeal collateral flow.

Authors:  F McVerry; D S Liebeskind; K W Muir
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-01       Impact factor: 3.825

2.  Formation of a Liquid Jet by Interaction between a Laser-induced Bubble and a Shock Wave.

Authors:  T Hirano; M Komatsu; M Ezura; H Uenohara; A Takahashi; K Takayama; T Yoshimoto
Journal:  Interv Neuroradiol       Date:  2002-01-10       Impact factor: 1.610

Review 3.  The role of calcium antagonists in the treatment of cerebrovascular disease.

Authors:  J J Murphy
Journal:  Drugs Aging       Date:  1992 Jan-Feb       Impact factor: 3.923

4.  Relationship between vascular enhancement, cerebral hemodynamics, and MR angiography in cases of acute stroke.

Authors:  P Pantano; D Toni; F Caramia; A Falcou; M Fiorelli; C Argentino; L M Fantozzi; L Bozzao
Journal:  AJNR Am J Neuroradiol       Date:  2001-02       Impact factor: 3.825

5.  On the search for the perfect mismatch!

Authors:  M A Almekhlafi
Journal:  AJNR Am J Neuroradiol       Date:  2014-06-12       Impact factor: 3.825

6.  Effect of the Interaction between Recanalization and Collateral Circulation on Functional Outcome in Acute Ischaemic Stroke.

Authors:  Salvatore Mangiafico; Valentina Saia; Patrizia Nencini; Ilaria Romani; Vanessa Palumbo; Giovanni Pracucci; Arturo Consoli; Andrea Rosi; Leonardo Renieri; Sergio Nappini; Nicola Limbucci; Domenico Inzitari; Gian Franco Gensini
Journal:  Interv Neuroradiol       Date:  2014-12-05       Impact factor: 1.610

7.  Distal hyperintense vessels on FLAIR: an MRI marker for collateral circulation in acute stroke?

Authors:  K Y Lee; L L Latour; M Luby; A W Hsia; J G Merino; S Warach
Journal:  Neurology       Date:  2009-02-11       Impact factor: 9.910

8.  Hyperdense middle cerebral artery CT sign. Comparison with angiography in the acute phase of ischemic supratentorial infarction.

Authors:  S Bastianello; A Pierallini; C Colonnese; G Brughitta; U Angeloni; M Antonelli; L M Fantozzi; C Fieschi; L Bozzao
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

9.  Ischemic postconditioning protects against focal cerebral ischemia by inhibiting brain inflammation while attenuating peripheral lymphopenia in mice.

Authors:  S P Joo; W Xie; X Xiong; B Xu; H Zhao
Journal:  Neuroscience       Date:  2013-04-13       Impact factor: 3.590

Review 10.  Advances in transcranial Doppler ultrasonography.

Authors:  Georgios Tsivgoulis; Andrei V Alexandrov; Michael A Sloan
Journal:  Curr Neurol Neurosci Rep       Date:  2009-01       Impact factor: 5.081

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.